K
Kezar Life Sciences, Inc. (KZR)
NCM – Real vaqt narxi. Valyuta: USD
7.29
0.00 (0.00%)
Yopilishda: May 8, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
7.29
0.00 (0.00%)
Yopilishda: May 8, 2026, 4:00 PM EDT
Kezar Life Sciences, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda immunitet vositachiligidagi kasalliklarda qondirilmagan ehtiyojlarni davolash uchun noyob kichik molekulali terapevtik vositalarni kashf qilish va ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi zetomipzomib (KZR-616) bo'lib, u lupus nefriti, dermatomiyozit va polimiyozit; hamda tizimli qizil yug'richada 1b/2 fazali klinik sinovlari kabi turli ko'rsatkichlar uchun selektiv immunoproteasoma inhibitörüdür. Kezar Life Sciences, Inc. 2015-yilda tashkil etilgan va Kaliforniyaning Janubiy San-Fransisko shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Christopher J. Kirk Ph.D. | Co-Founder, CEO & Director |
| Dr. Jack Taunton Ph.D. | Co-Founder |
| Mr. John Franklin Fowler | Co-Founder & Director |
| Mr. Marc L. Belsky C.P.A. | CFO & Secretary |
| Mr. Mark Schiller | Chief Operations Officer |
| Ms. Pichi Chiang | Senior Vice President & Controller |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | 10-K/A | kzr-20251231.htm |
| 2026-04-14 | SC 14D9 | ny20070329x1_sc14d9.htm |
| 2026-04-13 | SC TO-T | ny20070168x1_sctot.htm |
| 2026-04-03 | 8-K | kzr-20260401.htm |
| 2026-03-30 | SC14D9C | d280757dsc14d9c.htm |
| 2026-03-27 | 10-K | kzr-20251231.htm |
| 2026-03-12 | 8-K | kzr-20260306.htm |
| 2025-11-12 | 8-K | kzr-20251112.htm |
| 2025-11-07 | 8-K | kzr-20251106.htm |
| 2025-10-22 | 8-K | kzr-20251020.htm |